Related Experiment Videos
Short-Term Effects of Microglia-Specific Mitochondrial Dysfunction on Amyloidosis in Transgenic Models of Alzheimer's
Johannes Steffen1,2, Jan Stenzel1, Saleh Ibrahim2
1Department of Neurology, University of Rostock, Neurodegeneration Research Lab (NRL), Germany.
Abstract:
Reduction of mitochondrial activity is a subtle and early event in the pathogenesis of Alzheimer's disease. Mitochondrial damage and consequentially enhanced production of reactive oxygen species is particularly occurring in the vicinity of amyloid plaques. Since all cells are affected by mitochondrial damage, analyses of cell type-specific effects are challenging. To study the impact of mitochondrial alterations on microglial activity in a homogeneous genetic background, we generated bone marrow chimeras of irradiated 46-days-old APP-transgenic mice. For reconstitution, bone marrow from CX3CR1-eGFP mice with mitochondria of either non-obese diabetic or C57BL/6J animals was utilized. Successful reconstitution was evident in 100-day-old animals, by the presence of eGFP-positive cells in liver and spleen. In the brain, one-third of IBA1-positive microglia cells were newly recruited eGFP-expressing cells. Although donor-derived microglia were equally located in the proximity of amyloid plaques, no difference was observed in either the amyloid level, total number, or microglial coverage of plaques. These results indicate that during this brief and early phase of amyloid deposition, beneficial mitochondrial alterations in the newly recruited third of microglial cells were not sufficient to affect the amyloidosis in APP-transgenic mice.
Insights
Mitochondrial dysfunction is an early Alzheimer's disease event. Newly recruited microglia with altered mitochondria did not impact amyloid plaque development in APP-transgenic mice during early disease stages.
Area of Science:
- Neuroscience
- Cell Biology
- Mitochondrial Biology
Background:
- Mitochondrial activity reduction is an early Alzheimer's disease (AD) pathogenesis event.
- Mitochondrial damage and reactive oxygen species production are prominent near amyloid plaques.
- Studying cell-type-specific effects of mitochondrial damage is challenging due to widespread cellular impact.
Purpose of the Study:
- To investigate the impact of mitochondrial alterations on microglial activity within a controlled genetic background.
- To assess whether mitochondrial changes in newly recruited microglia influence amyloid pathology in a mouse model of Alzheimer's disease.
Main Methods:
- Generation of bone marrow chimeras using APP-transgenic mice and CX3CR1-eGFP mice with varying mitochondrial origins (NOD or C57BL/6J).
- Irradiation of 46-day-old APP-transgenic mice followed by bone marrow reconstitution.
- Analysis of eGFP-positive cell engraftment in peripheral organs and brain microglia (IBA1-positive cells) at 100 days of age.
Main Results:
- Successful reconstitution confirmed by eGFP-positive cells in liver and spleen.
- Approximately one-third of brain microglia were newly recruited eGFP-expressing cells.
- Donor-derived microglia were found near amyloid plaques, but no significant differences were observed in amyloid levels, total plaque number, or microglial plaque coverage.
Conclusions:
- Mitochondrial alterations in newly recruited microglia did not affect amyloid deposition in the early stages of APP-transgenic mice.
- The brief period of early amyloid deposition may limit the therapeutic potential of mitochondrial interventions in microglia.
- Further research is needed to understand the long-term effects and potential therapeutic windows for mitochondrial modulation in Alzheimer's disease.